Publications

Does intracranial pressure vary based on external ventricular drainage? A real-world clinical observation study

Kwon D, Riskey L, Kamal A, Doyle BR, Louthen B, Marshall JL, Ruxmohan SD, Salter A, Olson DW 2025 Mar 38

Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis

Salter A, Lancia S, Cutter GR, Fox RJ, Marrie RA 2025 Jan 104 e210149

Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis

Salter A, Lancia S, Cutter GR, Fox RJ, Marrie RA 2025

Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis

Strijbis EM, Mostert J, Comtois J, Salter A, Repovic P, Bowen JD, Uitdehaag BM, Cutter GR, Koch MW 2024 Dec 104

Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease: Analysis of the PRECEPT and DATATOP Trial Datasets

Koch MW, Kalia LV, Sarna JR, Wile D, Mestre TA, Schlossmacher MG, Mostert J, Strijbis EM, Uitdehaag B, Salter A, Cutter GR 2024 Dec 104

Cognitive rehabilitation effects on grey matter volume and Go-NoGo activity in progressive multiple sclerosis: results from the CogEx trial

Author Collaboration tC, Rocca MA, Valsasina P, Romanò F, Tedone N, Amato MP, Brichetto G, Boccia VD, Chataway J, Chiaravalloti ND, Cutter G, Dalgas U, Deluca J, Farrell RA, Feys P, Freeman J, Inglese M, Meza C, Motl RW, Salter A, Sandroff BM, Feinstein A, Filippi M, Michelsen AS, Madsen LE, Jørgensen ML, Diedmann MD, Keytsman C, Vanzeir E, Lenaerts J, Knevels L, D'Hooge M, Weerdt ND, Veldkamp R, Donnee R, Vandecasteele S, Vandael V, Cordani C, Sibilia M, Vizzino C, Riccitelli GC, Preziosa P, Podda J, Pedullà L, Tacchino A, Smith A, Bichler B, Morecraft J, Dibenedetto M, Moore N, Holme C 2024 Dec 95 1139-1149

There Is Significant Within-Subject Variation in the Time from Light Stimulus to Maximum Pupil Constriction Among Healthy Controls

Kamal A, Kim Y, Salter A, Gunna S, Nairon EB, Olson DW 2024 Dec 13

Comorbidity and Disease Activity in Multiple Sclerosis

Salter A, Lancia S, Kowalec K, Fitzgerald KC, Marrie RA 2024 Nov 81

Clinical outcome and cost effectiveness of acute ischemic stroke transfers for endovascular reperfusion therapy from geographically distant counties: Stroke transfer outcomes

Ray B, Mathews EP, Hernandez RS, Glaser KR, Washington HH, Salter A, Olson DW, Aiyagari V 2024 Nov 33

Evidence of symptom specificity for depression in multiple sclerosis: A two sample Mendelian randomization study

Hu C, Vasileiou ES, Salter A, Marrie RA, Kowalec K, Fitzgerald KC 2024 Nov 91

Heterogeneity of aerobic fitness changes with exercise training in progressive multiple sclerosis: Secondary, exploratory analysis of data from the CogEx trial

Author Collaboration CR, Motl RW, Sandroff BM, Hernandez RS, Amato MP, Brichetto G, Chataway J, Chiaravalloti ND, Cutter G, Dalgas U, DeLuca J, Farrell R, Feys P, Filippi M, Freeman J, Inglese M, Meza C, Rocca MA, Salter A, Feinstein A 2024 Oct 10

Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosis

Connolly L, Chatfield S, Freeman J, Salter A, Amato MP, Brichetto G, Chataway J, Chiaravalloti ND, Cutter G, DeLuca J, Dalgas U, Farrell R, Feys P, Filippi M, Inglese M, Meza C, Moore NB, Motl RW, Rocca MA, Sandroff BM, Feinstein A 2024 Oct 90

Author Response: Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations

Salter A, Lancia S, Kowalec K, Fitzgerald KC, Marrie RA 2024 Sep 103

New Requirements in the Reporting of Randomized Controlled Trials Published in Neurology to Foster Greater Transparency

Ziegler A, Eliasziw M, Howard VJ, Kerr WT, Salter A, Schneider AL, Merino JG 2024 Sep 103

Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis Patients

Brier MR, Schindler SE, Salter A, Perantie D, Shelley N, Judge B, Keefe S, Kirmess KM, Verghese PB, Yarasheski KE, Venkatesh V, Raji CA, Gordon BA, Bateman RJ, Morris JC, Naismith RT, Holtzman DM, Benzinger TL, Cross AH 2024 Sep 96 453-459

Rationale and methodology for examining the combination of aerobic exercise and cognitive rehabilitation on new learning and memory in persons with multiple sclerosis and mobility disability: Protocol for a randomized controlled trial

Wender CL, Arbelaez O, Tong TT, Salter A, Wylie GR, Motl RW, Sandroff BM, Chiaravalloti ND 2024 Sep 144

Access to Care and Health-Related Quality of Life in Multiple Sclerosis

Marrie RA, Lancia S, Cutter GR, Fox RJ, Salter A 2024 Aug 14

Association of patient-reported cognitive impairment with quality of life and employment in multiple sclerosis

Lancia S, Marrie RA, Cutter G, Fox RJ, Salter A 2024 Jul 87

Social Cognitive Theory Variables as Correlates of Physical Activity Behavior Among Hispanics With Multiple Sclerosis

Silveira SL, Motl RW, Salter A, Marquez DX 2024 Jun 105 1083-1088

Focusing on neural mechanisms of exercise training benefits in multiple sclerosis

Sandroff BM, Motl RW, Salter A 2024 Jun 86

Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis

Kowalec K, Harder A, Dolovich C, Fitzgerald KC, Salter A, Lu Y, Bernstein CN, Bolton JM, Cutter G, Fisk JD, Gelernter J, Graff LA, Hägg S, Hitchon CA, Levey DF, Lublin FD, McKay KA, Patten S, Patki A, Stein MB, Tiwari HK, Wolinsky JS, Marrie RA 2024 Jun 11 1393-1404

Female-specific pancreatic cancer survival from CT imaging of visceral fat implicates glutathione metabolism in solid tumors

Ballard DH, Nguyen GK, Atagu N, Camps G, Salter A, Jaswal S, Naeem M, Ludwig DR, Mellnick VM, Peterson LR, Hawkins WG, Fields RC, Luo J, Ippolito JE 2024 Jun 31 2312-2323

Prevalence and Associated Clinical Characteristics of Walking-Related Motor, Cognitive, and Fatigability in Progressive Multiple Sclerosis: Baseline Results From the CogEx Study

Ramari C, D’hooge M, Dalgas U, Feinstein A, Amato MP, Brichetto G, Chataway J, Chiaravalloti ND, Cutter GR, DeLuca J, Farrell R, Filippi M, Freeman J, Inglese M, Meza C, Motl RW, Rocca MA, Sandroff BM, Salter A, Kos D, Feys P 2024 May 38 327-338

Diffusion basis spectrum imaging and diffusion tensor imaging predict persistent black hole formation in multiple sclerosis

Wooliscroft L, Salter A, Adusumilli G, Levasseur VA, Sun P, Lancia S, Perantie DC, Trinkaus K, Naismith RT, Song SK, Cross AH 2024 Apr 84

Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force

Parciak T, Geys L, Helme A, van der Mei I, Hillert J, Schmidt H, Salter A, Zakaria M, Middleton R, Stahmann A, Dobay P, Hernandez Martinez-Lapiscina E, Iaffaldano P, Plueschke K, Rojas JI, Sabidó M, Magyari M, van der Walt A, Arickx F, Comi G, Peeters LM 2024 Mar 30 396-418

Increased healthcare utilization in the year before multiple sclerosis diagnosis

Razzak AN, Hernandez RS, Salter A, Obeidat AZ 2024 Mar 83

Off-Road Testing: Outcome Reporting Bias in Multiple Sclerosis Trials

Marrie RA, Salter A 2024 Feb 102

Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations

Salter A, Lancia S, Kowalec K, Fitzgerald KC, Marrie RA 2024 Feb 102

Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND)

Vernino S, Hopkins S, Bryarly M, Hernandez RS, Salter A 2024 Feb 34 153-163

Era of COVID-19 in Multiple Sclerosis Care

Krett JD, Salter A, Newsome SD 2024 Feb 42 319-340

Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations

Stahmann A, Craig E, Ellenberger D, Fneish F, Frahm N, Marrie RA, Middleton R, Nicholas R, Rodgers J, Warnke C, Salter A 2024 Jan 17

Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design

Sguigna PV, Hussain RZ, Okai A, Blackburn KM, Tardo L, Madinawala M, Korich J, Lebson LA, Kaplan J, Salter A, Manouchehri N, Stuve O 2024 Jan 17

Increased White Matter Aerobic Glycolysis in Multiple Sclerosis

Brier MR, Judge B, Ying C, Salter A, An H, Patel A, Wang Q, Wang Y, Cross AH, Naismith RT, Benzinger TL, Goyal MS 2024

Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosis

Ghezzi L, Tosti V, Shi L, Cantoni C, Mikesell R, Lancia S, Zhou Y, Obert K, Dula C, Sen MK, Ge A, Tolentino M, Bollman B, Don AS, Matarese G, Colamatteo A, Rocca CL, Lepore MT, Raji CA, Rahmani F, Wu GF, Naismith RT, Fontana L, Cross AH, Salter A, Piccio L 2024

Evaluation of the impact of neurology electronic consults (e-consults): Experiences of a neurology resident clinic in a safety-net hospital

Tardo L, Hirczy S, Blackburn K, Mejia M, Salter A, Huynh M, Khan S 2024

Priority setting: women’s health topics in multiple sclerosis

Ross L, Finlayson M, Amato MP, Cohen JA, Hellwig K, Tintore M, Vukusic S, Salter A, Marrie RA 2024 15

The effects of cognitive rehabilitation combined with aerobic exercise or stretching-and-toning on new learning and memory in persons with moderate-to-severe TBI: Protocol for a randomized controlled trial

Sandroff BM, Weber E, Wylie GR, Wender CL, Goverover Y, Lercher K, Tong TT, Robinson B, Moore N, Salter A, DeLuca J, Chiaravalloti ND 2023 Nov 134

Using a Bayesian Reanalysis Approach to Evaluate the Probability of Benefit From the MISTIE Intervention

Salter A, Kerr WT 2023 Oct 101 687-688

Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial

Author Collaboration CR, Feinstein A, Amato MP, Brichetto G, Chataway J, Chiaravalloti ND, Cutter G, Dalgas U, DeLuca J, Farrell R, Feys P, Filippi M, Freeman J, Inglese M, Meza C, Motl RW, Rocca MA, Sandroff BM, Salter A, Pietrusz A, Tacchino A, Smith A, Michelsen AS, Kristin A, Bichler B, Truax B, Vizzino C, Jones CD, Holme C, Smith C, Keytsman C, Pollio C, Cole C, Niccolai C, Cordani C, Colombo E, Pelosin E, Vanzeir E, Vannetti F, Gerli F, Maranta F, Riccitelli G, Pasquini G, Wilkinson H, Mosca I, Braisher J, Baird J, Podda J, Morecraft J, Lenaerts J, Puopolo J 2023 Oct 22 912-924

Assessment of differential item functioning of the PHQ-9, HADS-D and PROMIS-depression scales in persons with and without multiple sclerosis

Author Collaboration ft, Marrie RA, Lix LM, Bolton JM, Fisk JD, Fitzgerald KC, Graff LA, Hitchon CA, Kowalec K, Marriott JJ, Patten SB, Salter A, Bernstein CN 2023 Sep 172

Central Vein Sign in Pediatric Multiple Sclerosis and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Harrison KL, Gaudioso C, Levasseur VA, Dunham SR, Schanzer N, Keuchel C, Salter A, Goyal MS, Mar S 2023 Sep 146 21-25

Polygenicity of Comorbid Depression in Multiple Sclerosis

Kowalec K, Fitzgerald KC, Salter A, Dolovich C, Harder A, Bernstein CN, Bolton J, Cutter GR, Graff LA, Hägg S, Hitchon CA, Lu Y, Lublin F, Mckay KA, Patten SB, Patki A, Tiwari HK, Wolinsky JS, Marrie RA 2023 Aug 101 E522-E532

Improving the efficiency of clinical trials in multiple sclerosis

Marrie RA, Sormani MP, Apap Mangion S, Bovis F, Cheung WY, Cutter GR, Feys P, Hill MD, Koch MW, McCreary M, Mowry EM, Park JJ, Piehl F, Salter A, Chataway J 2023 Aug 29 1136-1148

Assessing everyday functional activity in cognitively impaired people with multiple sclerosis: The use of Actual RealityTM

Goverover Y, Salter A, DeLuca J 2023 Aug 29 1107-1117

Profiling cognitive–motor interference in a large sample of persons with progressive multiple sclerosis and impaired processing speed: results from the CogEx study

Author Collaboration tC, Veldkamp R, D’hooge M, Sandroff BM, DeLuca J, Kos D, Salter A, Feinstein A, Amato MP, Brichetto G, Chataway J, Farrell R, Chiaravalloti ND, Dalgas U, Filippi M, Freeman J, Motl RW, Meza C, Inglese M, Rocca MA, Cutter G, Feys P 2023 Jun 270 3120-3128

Abnormal thalamic functional connectivity correlates with cardiorespiratory fitness and physical activity in progressive multiple sclerosis

Author Collaboration CR, Romanò F, Motl RW, Valsasina P, Amato MP, Brichetto G, Bruschi N, Chataway J, Chiaravalloti ND, Cutter G, Dalgas U, DeLuca J, Farrell R, Feys P, Freeman J, Inglese M, Meza C, Salter A, Sandroff BM, Feinstein A, Rocca MA, Filippi M 2023 Jun 270 3213-3224

Severity and worsening of fatigue among individuals with multiple sclerosis

Salter A, Keenan A, Le HH, Gandhi K, Ait-Tihyaty M, Lancia S, Cutter GR, Fox RJ, Marrie RA 2023 Apr 9

Physical activity as a correlate of symptoms, quality of life, comorbidity, and disability status in Hispanics with multiple sclerosis

Silveira SL, Motl RW, Marquez DX, Lancia S, Salter A 2023 Apr 16

Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis

Author Collaboration tR, Preziosa P, Rocca MA, Pagani E, Valsasina P, Amato MP, Brichetto G, Bruschi N, Chataway J, Chiaravalloti ND, Cutter G, Dalgas U, DeLuca J, Farrell R, Feys P, Freeman J, Inglese M, Meani A, Meza C, Motl RW, Salter A, Sandroff BM, Feinstein A, Filippi M 2023 Mar 270 1543-1563

Attitudes of people with multiple sclerosis toward brain donation

Marrie RA, Kosowan L, Cutter GR, Fox RJ, Salter A 2023 Jan 14

Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis

Vasileiou ES, Hu C, Bernstein CN, Lublin F, Wolinsky JS, Cutter GR, Sotirchos ES, Kowalec K, Salter A, Saidha S, Mowry EM, Calabresi PA, Marrie RA, Fitzgerald KC 2023 Jan 10

A narrative review of neuro-ophthalmologic disease in African Americans and Hispanics with multiple sclerosis

Tardo L, Salter A, Truong-Le MN, Horton L, Blackburn KM, Sguigna PV 2023 Jan 14

A Systematic Review of the Validity and Reliability of the Patient-Determined Disease Steps Scale

Marrie RA, McFadyen C, Yaeger L, Salter A 2023 Jan 25 20-25

Multiple sclerosis progression: time for a new mechanism-driven framework

Author Collaboration IA, Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J, Marrie RA, Montalban X, Yong VW, Thompson AJ, Reich DS, Amato MP, Banwell B, Barkhof F, Chataway J, Chitnis T, Comi G, Derfuss T, Finlayson M, Goldman M, Green A, Hellwig K, Kos D, Miller A, Mowry E, Oh J, Salter A, Sormani MP, Tintore M, Tremlett H, Trojano M, van der Walt A, Vukusic S, Waubant E 2023 Jan 22 78-88

Etiology, effects and management of comorbidities in multiple sclerosis: recent advances

Marrie RA, Fisk JD, Fitzgerald K, Kowalec K, Maxwell C, Rotstein D, Salter A, Tremlett H 2023 14

Qualitative imaging features of pancreatic neuroendocrine neoplasms predict histopathologic characteristics including tumor grade and patient outcome

Yano M, Shetty AS, Williams GA, Lancia S, Trikalinos NA, Hammill CW, Hawkins WG, Salter A, Chatterjee D 2022 Dec 47 3971-3985

The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx study

Author Collaboration tC, Feinstein A, Amato MP, Brichetto G, Chataway J, Chiaravalloti ND, Cutter G, Dalgas U, DeLuca J, Farrell R, Feys P, Filippi M, Freeman J, Inglese M, Meza C, Motl RW, Rocca MA, Sandroff BM, Salter A 2022 Dec 269 6202-6210

Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity

Simpson-Yap S, Pirmani A, Kalincik T, De Brouwer E, Geys L, Parciak T, Helme A, Rijke N, Hillert JA, Moreau Y, Edan G, Sharmin S, Spelman T, Mcburney R, Schmidt H, Bergmann AB, Braune S, Stahmann A, Middleton RM, Salter A, Bebo B, Van Der Walt A, Butzkueven H, Ozakbas S, Boz C, Karabudak R, Alroughani R, Rojas JI, Van Der Mei IA, Sciascia Do Olival G, Magyari M, Alonso RN, Nicholas RS, Chertcoff AS, De Torres AZ, Arrambide G, Nag N, Descamps A, Costers L, Dobson R, Miller A, Rodrigues P, Prčkovska V, Comi G, Peeters LM 2022 Nov 9

Physical and Mental Health-Related Quality of Life Trajectories Among People With Multiple Sclerosis

O'Mahony J, Salter A, Ciftci-Kavaklioglu B, Fox RJ, Cutter GR, Marrie RA 2022 Oct 99 E1538-E1548

Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β

Simpson-Yap S, Pirmani A, De Brouwer E, Peeters LM, Geys L, Parciak T, Helme A, Hillert J, Moreau Y, Edan G, Spelman T, Sharmin S, McBurney R, Schmidt H, Bergmann A, Braune S, Stahmann A, Middleton R, Salter A, Bebo B, van der Walt A, Butzkueven H, Ozakbas S, Karabudak R, Boz C, Alroughani R, Rojas JI, van der Mei I, Sciascia do Olival G, Magyari M, Alonso R, Nicholas R, Chertcoff A, Zabalza A, Arrambide G, Nag N, Descamps A, Costers L, Dobson R, Miller A, Rodrigues P, Prčkovska V, Comi G, Kalincik T 2022 Oct 66

Predictors of Clinical Outcomes of Pharmacomechanical Catheter-Directed Thrombolysis for Acute Iliofemoral Deep Vein Thrombosis: Analysis of a Multicenter Randomized Trial

Thukral S, Salter A, Lancia S, Kahn SR, Vedantham S 2022 Oct 33 1161-1170.e11

The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosis

Chiaravalloti ND, DeLuca J, Salter A, Amato MP, Brichetto G, Chataway J, Dalgas U, Farrell R, Feys P, Filippi M, Freeman J, Inglese M, Meza C, Moore NB, Motl RW, Rocca MA, Sandroff BM, Cutter G, Feinstein A 2022 Oct 28 1783-1792

COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes

Salter A, Cross AH, Cutter GR, Fox RJ, Li DK, Bebo B, Halper J, Kanellis P, Rammohan K, Newsome SD 2022 Sep 65

Rates and patterns of physical activity among Hispanics with multiple sclerosis in the NARCOMS Registry

Silveira SL, Motl RW, Marquez DX, Salter A 2022 Sep 65

Depressive symptom trajectories and polygenic risk scores in individuals with an immune-mediated inflammatory disease

Author Collaboration ft, Kowalec K, Salter A, Fitzgerald KC, Patel M, Han J, Lu Y, Bolton JM, Hitchon C, Bernstein CN, Patten S, Graff LA, Marriott JJ, Marrie RA 2022 Jul 77 21-28

Racial disparities in skin tone representation of dermatomyositis rashes: A systematic review

Babool S, Bhai SF, Sanderson C, Salter A, Christopher-Stine L 2022 Jun 61 2255-2261

Disparities in Telehealth Care in Multiple Sclerosis

Marrie RA, Kosowan L, Cutter G, Fox R, Salter A 2022 Jun 12 223-233

Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma

Jaswal S, Sanders V, Pullarkat P, Teja S, Salter A, Watkins MP, Atagu N, Ludwig DR, Mhlanga J, Mellnick VM, Peterson LR, Bartlett NL, Kahl BS, Fehniger TA, Ghobadi A, Cashen AF, Mehta-Shah N, Ippolito JE 2022 Jun 14

Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx study

Sandroff BM, Motl RW, Amato MP, Brichetto G, Chataway J, Chiaravalloti ND, Cutter GR, Dalgas U, DeLuca J, Farrell R, Feys P, Filippi M, Freeman J, Inglese M, Meza C, Rocca MA, Salter A, Feinstein A 2022 Jun 28 1091-1100

Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies

Porwal MH, Salter A, Patel D, Obeidat AZ 2022 Jun 14

Quality Control of Magnetic Resonance Elastography Using Percent Measurable Liver Volume Estimation

Ballard DH, Ludwig DR, Fraum TJ, Salter A, Narra VR, Shetty AS 2022 Jun 55 1890-1899

Sources of Cannabis Information and Medical Guidance for Neurologic Use: NARCOMS Survey of People Living With Multiple Sclerosis

Salter A, Cutter G, Marrie RA, Nichol K, Steinerman JR, Smith KM, Fox RJ 2022 Apr 12 102-112

Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis

Marrie RA, Dolovich C, Cutter GR, Fox RJ, Salter A 2022 Apr 8

The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience

Author Collaboration tC, Feinstein A, Amato MP, Brichetto G, Chataway J, Chiaravalloti ND, Cutter G, Dalgas U, DeLuca J, Farrell R, Feys P, Filippi M, Freeman J, Inglese M, Meza C, Motl R, Rocca MA, Sandroff BM, Salter A 2022 Apr 269 1758-1763

Stronger Microstructural Damage Revealed in Multiple Sclerosis Lesions With Central Vein Sign by Quantitative Gradient Echo MRI

Levasseur VA, Xiang B, Salter A, Yablonskiy DA, Cross AH 2022 Mar 14

Alterations of host-gut microbiome interactions in multiple sclerosis

Cantoni C, Lin Q, Dorsett Y, Ghezzi L, Liu Z, Pan Y, Chen K, Han Y, Li Z, Xiao H, Gormley M, Liu Y, Bokoliya S, Panier H, Suther C, Evans E, Deng L, Locca A, Mikesell R, Obert K, Newland P, Wu Y, Salter A, Cross AH, Tarr PI, Lovett-Racke A, Piccio L, Zhou Y 2022 Feb 76

Controlling for Multiplicity, Eligibility, and Exclusions

Salter A, Miller JP 2022 Jan 729-737

Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis

Marrie RA, Dolovich C, Cutter GR, Fox RJ, Salter A 2021 Dec 12

Effect of Intravenous Thrombolysis on Clot Survival during Mechanical Thrombectomy in Acute Large Vessel Occlusion Strokes

Shehabeldin M, Eby B, Wallace AN, Salter A, Chatterjee AR, Osbun JW, Moran CJ, Cross DT, Kansagra AP 2021 Dec 89 1027-1032

Associations of Disease-Modifying Therapies with COVID-19 Severity in Multiple Sclerosis

Simpson-Yap S, De Brouwer E, Kalincik T, Rijke N, Hillert JA, Walton C, Edan G, Moreau Y, Spelman T, Geys L, Parciak T, Gautrais C, Lazovski N, Pirmani A, Ardeshirdavanai A, Forsberg L, Glaser A, McBurney R, Schmidt H, Bergmann AB, Braune S, Stahmann A, Middleton R, Salter A, Fox RJ, Van Der Walt A, Butzkueven H, Alroughani R, Ozakbas S, Rojas JI, Van Der Mei I, Nag N, Ivanov R, Sciascia Do Olival G, Dias AE, Magyari M, Brum D, Mendes MF, Alonso RN, Nicholas RS, Bauer J, Chertcoff AS, Zabalza A, Arrambide G, Fidao A, Comi G, Peeters L 2021 Nov 97 E1870-E1885

Mendelian randomization provides no evidence for a causal role in the bidirectional relationship between depression and multiple sclerosis

Harroud A, Marrie RA, Fitzgerald KC, Salter A, Lu Y, Patel M, Kowalec K 2021 Nov 27 2077-2084

Characterizing Long-term Disability Progression and Employment in NARCOMS Registry Participants with Multiple Sclerosis Taking Dimethyl Fumarate

Salter A, Lancia S, Cutter G, Fox RJ, Marrie RA, Mendoza JP, Lewin JB 2021 Nov 23 239-244

NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights

Marrie RA, Cutter GR, Fox RJ, Vollmer T, Tyry T, Salter A 2021 Nov 23 276-285

A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis

Salter A, Fox RJ, Cutter G, Marrie RA, Nichol KE, Steinerman JR, Smith KM 2021 Nov 23 245-252

Assessing Access to Five Types of Insurance by People with Multiple Sclerosis Using a Cross-sectional Online Survey

Miller DM, Cofield SS, Planchon SM, Givens SE, Salter A, Schmidt HK, Corlette S, Musil CC 2021 Nov 23 253-260

Guest Editorial

Marrie RA, Salter A 2021 Nov 23 4

Guest Editorial

Marrie RA, Salter A 2021 Nov 23 4

Comparison of radiation dose and image quality between contrast-enhanced single- and dual-energy abdominopelvic computed tomography in children as a function of patient size

Siegel MJ, Mhlanga JC, Salter A, Ramirez-Giraldo JC 2021 Oct 51 2000-2008

Comparative responsiveness of the health utilities index and the RAND-12 for multiple sclerosis

Marrie RA, Leung S, Cutter GR, Fox RJ, Salter A 2021 Oct 27 1781-1789

Assessment of Biological Interactions Between Multiple Sclerosis Status and Depression for Mortality

Salter A 2021 Sep 97 617-618

COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry

Newsome SD, Cross AH, Fox RJ, Halper J, Kanellis P, Bebo B, Li D, Cutter GR, Rammohan KW, Salter A 2021 Sep 8

Clinical Outcomes of a Pharmacomechanical Catheter-Directed Venous Thrombolysis Strategy that Included Rheolytic Thrombectomy in a Multicenter Randomized Trial

Vedantham S, Salter A, Lancia S, Lewis L, Thukral S, Kahn SR 2021 Sep 32 1296-1309.e7

Alterations of the gut mycobiome in patients with MS

Shah S, Locca A, Dorsett Y, Cantoni C, Ghezzi L, Lin Q, Bokoliya S, Panier H, Suther C, Gormley M, Liu Y, Evans E, Mikesell R, Obert K, Salter A, Cross AH, Tarr PI, Lovett-Racke A, Piccio L, Zhou Y 2021 Sep 71

Differing Impact of Disease-Modifying Therapy on Relapse and Progression: Time to Consider Inflammation and Neuroprotection Separately?

Dobson R, Salter A 2021 Aug 97 407-408

Uptake and Attitudes about Immunizations in People with Multiple Sclerosis

Marrie RA, Kosowan L, Cutter GR, Fox R, Salter A 2021 Aug 11 327-334

Results of the 2019 Survey of the American Alliance of Academic Chief Residents in Radiology

Ballard DH, Summers D, Hoegger MJ, Salter A, Gould JE 2021 Jul 28 1018-1028

Differences in Self-Reported Physical and Behavioral Health in Musculoskeletal Patients Based on Physician Gender

Cheng AL, Fogarty AE, Calfee RP, Salter A, Colditz GA, Prather H 2021 Jul 13 720-728

Outcomes and Risk Factors Associated with SARS-CoV-2 Infection in a North American Registry of Patients with Multiple Sclerosis

Salter A, Fox RJ, Newsome SD, Halper J, Li DK, Kanellis P, Costello K, Bebo B, Rammohan K, Cutter GR, Cross AH 2021 Jun 78 699-708

Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database

Caldito NG, Shirani A, Salter A, Stuve O 2021 Jun 27 1066-1076

The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis

Author Collaboration ob, Chiaravalloti ND, Amato MP, Brichetto G, Chataway J, Dalgas U, DeLuca J, Meza C, Moore NB, Feys P, Filippi M, Freeman J, Inglese M, Motl R, Rocca MA, Sandroff BM, Salter A, Cutter G, Feinstein A 2021 May 268 1598-1607

Diagnostic performance of LI-RADS version 2018 for evaluation of pediatric hepatocellular carcinoma

Khanna G, Chavhan GB, Schooler GR, Fraum TJ, Alazraki AL, Squires JH, Salter A, Podberesky DJ, Towbin AJ 2021 Apr 299 190-199

Increased Utilization of Total Joint Arthroplasty after Medicaid Expansion

Dy CJ, Salter A, Barker A, Brown D, Keller M, Olsen MA 2021 Mar 103 524-531

Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry

Galdieri L, Jash A, Malkova O, Mao DD, DeSouza P, Chu YE, Salter A, Campian JL, Naegle KM, Brennan CW, Wakimoto H, Oh ST, Kim AH, Chheda MG 2021 Feb 6

Data harmonization for collaborative research among MS registries: A case study in employment

Salter A, Stahmann A, Ellenberger D, Fneish F, Rodgers WJ, Middleton R, Nicholas R, Marrie RA 2021 Feb 27 281-289

Chemokine Receptor 2–targeted Molecular Imaging in Pulmonary Fibrosis

Brody SL, Gunsten SP, Luehmann HP, Sultan DH, Hoelscher M, Heo GS, Pan J, Koenitzer JR, Lee EC, Huang T, Mpoy C, Guo S, Laforest R, Salter A, Russell TD, Shifren A, Combadiere C, Lavine KJ, Kreisel D, Humphreys BD, Rogers BE, Gierada DS, Byers DE, Gropler RJ, Chen DL, Atkinson JJ, Liu Y 2021 Jan 203 78-89

The impact of adjunctive tomosynthesis on screening mammography outcomes in two widely diverse radiology practices

Poplack SP, Patel AK, Salter A, Langley Blanton H, Murray D, McGuire C 2021 Jan 27 13-20

New applications for independent activities of daily living in measuring disability in multiple sclerosis

Salter A, Fox RJ, Tyry T, Cutter G, Marrie RA 2021 Jan 27 97-106

Disease-modifying therapy prescription patterns in people with multiple sclerosis by age

Zhang Y, Salter A, Jin S, Culpepper WJ, Cutter GR, Wallin M, Stuve O 2021 14

A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod

Salter A, Lancia S, Cutter G, Marrie RA, Mendoza JP, Lewin JB, Fox Mellen RJ 2021 14

Dynamic 18F-FDOPA-PET/MRI for the preoperative evaluation of gliomas: Correlation with stereotactic histopathology

Ponisio MR, McConathy JE, Dahiya SM, Miller-Thomas MM, Rich KM, Salter A, Wang Q, LaMontagne PJ, Guzmán Pérez-Carrillo GJ, Benzinger TL 2020 Dec 7 656-667

Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacomechanical Thrombolysis in a Multicenter Randomized Trial

Razavi MK, Salter A, Goldhaber SZ, Lancia S, Kahn SR, Weinberg I, Kearon C, Azene EM, Patel NH, Vedantham S 2020 Oct 31 1517-1528.e2

T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients

Ghezzi L, Cantoni C, Cignarella F, Bollman B, Cross AH, Salter A, Galimberti D, Cella M, Piccio L 2020 Sep 26 1172-1186

COVID-19 in people with multiple sclerosis: A global data sharing initiative

Peeters LM, Parciak T, Walton C, Geys L, Moreau Y, De Brouwer E, Raimondi D, Pirmani A, Kalincik T, Edan G, Simpson-Yap S, De Raedt L, Dauxais Y, Gautrais C, Rodrigues PR, McKenna L, Lazovski N, Hillert J, Forsberg L, Spelman T, McBurney R, Schmidt H, Bergmann A, Braune S, Stahmann A, Middleton R, Salter A, Bebo BF, Rojas JI, van der Walt A, Butzkueven H, van der Mei I, Ivanov R, Hellwig K, Sciascia do Olival G, Cohen JA, Van Hecke W, Dobson R, Magyari M, Brum DG, Alonso R, Nicholas R, Bauer J, Chertcoff A, de Sèze J, Louapre C, Comi G, Rijke N 2020 Sep 26 1157-1162

Optimal co-clinical radiomics: Sensitivity of radiomic features to tumour volume, image noise and resolution in co-clinical T1-weighted and T2-weighted magnetic resonance imaging

Roy S, Whitehead TD, Quirk JD, Salter A, Ademuyiwa FO, Li S, An H, Shoghi KI 2020 Sep 59

Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial

Salter A, Kowalec K, Fitzgerald KC, Cutter G, Marrie RA 2020 Aug 95 E446-E456

Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis

Marrie RA, Dufault B, Tyry T, Cutter GR, Fox RJ, Salter A 2020 Aug 26 1102-1110

A Color Flow Tract in Ultrasound-Guided Random Renal Core Biopsy Predicts Complications

Gagnon MH, Lin MF, Lancia S, Salter A, Yano M 2020 Jul 39 1335-1342

Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Marrie RA 2020 Jul 26 976-986

Fractures in the prodromal period of Parkinson disease

Camacho-Soto A, Gross A, Searles Nielsen S, Miller AN, Warden MN, Salter A, Racette BA 2020 Jun 94 E2448-E2456

Study protocol: Improving cognition in people with progressive multiple sclerosis: A multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx)

Feinstein A, Amato MP, Brichetto G, Chataway J, Chiaravalloti N, Dalgas U, Deluca J, Feys P, Filippi M, Freeman J, Meza C, Inglese M, Motl RW, Rocca MA, Sandroff BM, Salter A, Cutter G 2020 May 20

Clinical instrument to retrospectively capture levels of EDSS

Ciotti JR, Sanders N, Salter A, Berger JR, Cross AH, Chahin S 2020 Apr 39

Outcome of Lesser Metatarsophalangeal Joint Interpositional Arthroplasty With Tendon Allograft

Stautberg EF, Klein SE, McCormick JJ, Salter A, Johnson JE 2020 Mar 41 313-319

Associations between Self-Reported Symptoms and Gait Parameters Using In-Home Sensors in Persons with Multiple Sclerosis

Newland P, Salter A, Flach A, Flick L, Thomas FP, Gulick EE, Rantz M, Skubic M 2020 Mar 45 80-87

Dual antiplatelets in IV thrombolysis: How much is too much?

Lioutas VA, Salter A 2020 Feb 94 289-290

Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors

Fraum TJ, Cannella R, Ludwig DR, Tsai R, Naeem M, LeBlanc M, Salter A, Tsung A, Shetty AS, Borhani AA, Furlan A, Fowler KJ 2020 Feb 30 996-1007

Infectious disease consultation for candidaemia – Authors' reply

Mejia-Chew C, O'Halloran JA, Olsen MA, Stwalley D, Salter A, Powderly WG, Spec A 2020 Feb 20 165-166

An image processing algorithm to aid diagnosis of mesial temporal sclerosis in children: a case-control study

Strnad BS, Orlowski HL, Parsons MS, Salter A, Dahiya S, Sharma A 2020 Jan 50 98-106

Gender identity and sexual orientation affect health care satisfaction, but not utilization, in persons with Multiple Sclerosis

Khayambashi S, Salter A, Tyry T, Cutter GR, Fox RJ, Marrie RA 2020 Jan 37

Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials

Zhang Y, Gonzalez Caldito N, Shirani A, Salter A, Cutter G, Culpepper W, Wallin M, Kosa P, Bielekova B, Lublin F, Stϋve O 2020 13

Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia

Author Collaboration ft, Koenig LN, Day GS, Salter A, Keefe S, Marple LM, Long J, LaMontagne P, Massoumazada P, Snider BJ, Kanthamneni M, Raji CA, Ghoshal N, Gordon BA, Miller-Thomas M, Morris JC, Shimony JS, Benzinger TL 2020 26

Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria

Ludwig DR, Fraum TJ, Cannella R, Tsai R, Naeem M, LeBlanc M, Salter A, Tsung A, Fleckenstein J, Shetty AS, Borhani AA, Furlan A, Fowler KJ 2019 Dec 21 1697-1706

Crohn's Disease Is Associated With an Increased Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study Using Magnetic Resonance Proton Density Fat Fraction Mapping

McHenry S, Sharma Y, Tirath A, Tsai R, Mintz A, Fraum TJ, Salter A, Browning JD, Flores AG, Davidson NO, Fowler KJ, Ciorba MA, Deepak P 2019 Dec 17 2816-2818

Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation

Wang Q, Guzmán Pérez-Carrillo GJ, Ponisio MR, LaMontagne P, Dahiya S, Marcus DS, Milchenko M, Shimony J, Liu J, Chen G, Salter A, Massoumzadeh P, Miller-Thomas MM, Rich KM, McConathy J, Benzinger TL, Wang Y 2019 Nov 14

Carbetocin reduces the need for additional uterotonics in elective caesarean delivery: a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials

Onwochei DN, Van Ross J, Singh PM, Salter A, Monks DT 2019 Nov 40 14-23

Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers

Cammack AJ, Atassi N, Hyman T, Van Den Berg LH, Harms M, Baloh RH, Brown RH, Van Es MA, Veldink JH, De Vries BS, Rothstein JD, Drain C, Jockel-Balsarotti J, Malcolm A, Boodram S, Salter A, Wightman N, Yu H, Sherman AV, Esparza TJ, McKenna-Yasek D, Owegi MA, Douthwright C, McCampbell A, Ferguson T, Cruchaga C, Cudkowicz M, Miller TM 2019 Oct 93 E1605-E1617

Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial

Author Collaboration ft, Weinberg I, Vedantham S, Salter A, Hadley G, Al-Hammadi N, Kearon C, Julian JA, Razavi MK, Gornik HL, Goldhaber SZ, Comerota AJ, Kindzelski AL, Schainfeld RM, Angle JF, Misra S, Schor JA, Hurst D, Jaff MR 2019 Oct 24 442-451

Functional gastrointestinal disorders negatively affect health-related quality of life in MS

Marrie RA, Leung S, Tyry T, Cutter GR, Fox R, Salter A 2019 Oct 9 381-390

Propensity-matched comparison of transjugular intrahepatic portosystemic shunt placement techniques: Intracardiac echocardiography (ICE) versus fluoroscopic guidance

Ramaswamy RS, Charalel R, Guevara CJ, Tiwari T, Akinwande O, Kim SK, Salter A, Darcy M, Malone CD 2019 Sep 57 40-44

Measurement repeatability of 18F-FDG PET/CT versus 18F-FDG PET/MRI in solid tumors of the pelvis

Fraum TJ, Fowler KJ, Crandall JP, Laforest RA, Salter A, An H, Jacobs MA, Grigsby PW, Dehdashti F, Wahl RL 2019 Aug 60 1080-1086

Repeatability of Quantitative Brown Adipose Tissue Imaging Metrics on Positron Emission Tomography with 18F-Fluorodeoxyglucose in Humans

Fraum TJ, Crandall JP, Ludwig DR, Chen S, Fowler KJ, Laforest RA, Salter A, Dehdashti F, An H, Wahl RL 2019 Jul 30 212-224.e4

CT IVC venogram: normalized quantitative criteria for patency and thrombosis

Mityul M, Kim DJ, Salter A, Yano M 2019 Jun 44 2262-2267

Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018

Ludwig DR, Fraum TJ, Cannella R, Ballard DH, Tsai R, Naeem M, LeBlanc M, Salter A, Tsung A, Shetty AS, Borhani AA, Furlan A, Fowler KJ 2019 Jun 44 2116-2132

The association of fatigue and social participation in multiple sclerosis as assessed using two different instruments

Salter A, Fox RJ, Tyry T, Cutter G, Marrie RA 2019 Jun 31 165-172

Clinical trials in multiple sclerosis: potential future trial designs

Manouchehri N, Zhang Y, Salter A, Hussain RZ, Hartung HP, Hemmer B, Linker R, Segal BM, Cutter G, Stüve O 2019 May 12

68Ga-Galmydar: A PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity

Sivapackiam J, Kabra S, Speidel S, Sharma M, Laforest R, Salter A, Rettig MP, Sharma V 2019 May 14

A survey of risk tolerance to multiple sclerosis therapies

Fox RJ, Cosenza C, Cripps L, Ford P, Mercer MB, Natarajan S, Salter A, Tyry T, Cofield SS 2019 Apr 92 E1634-E1642

Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Mowry EM, Marrie RA 2019 Apr 29 86-93

Formulating a Treatment Plan in Suspected Lymphoma: Ultrasound-Guided Core Needle Biopsy Versus Core Needle Biopsy and Fine-Needle Aspiration of Peripheral Lymph Nodes

Drylewicz MR, Watkins MP, Shetty AS, Lin MF, Salter A, Bartlett NL, Middleton WD, Yano M 2019 Mar 38 581-586

Evolution of clinical trials in multiple sclerosis

Zhang Y, Salter A, Wallström E, Cutter G, Stüve O 2019 Feb 12

Comfort discussing HIV pre-exposure prophylaxis with patients among physicians in an urban emergency department

Tortelli BA, Char DM, Crane JS, Powderly WG, Salter A, Chan PA, Patel RR 2019 Feb 80 E49-E52

Successful Linkage to Pre-Exposure Prophylaxis for HIV Prevention Using a Multicomponent Implementation Strategy among the Uninsured/Underinsured

Patel RR, Nunn AS, Mayer KH, McBride T, Brownson RC, Oliver C, Perez MM, Harrison LC, Salter A, Crane JS, Chan PA 2019 Feb 33 45-48

Use of eHealth and mHealth technology by persons with multiple sclerosis

Marrie RA, Leung S, Tyry T, Cutter GR, Fox R, Salter A 2019 Jan 27 13-19

Image processing to improve detection of mesial temporal sclerosis in adults

Dahi F, Parsons MS, Orlowski HL, Salter A, Dahiya S, Sharma A 2019 40 798-801

Evaluating the utility of a postprocessing algorithm for MRI evaluation of optic neuritis

Stunkel L, Sharma A, Parsons MS, Salter A, Van Stavern GP 2019 40 1043-1048

Magnetic resonance enterography features of small bowel Crohn's disease activity: An inter-rater reliability study of small bowel active inflammation in clinical practice setting

Tsai R, Mintz A, Lin M, Mhlanga J, Chiplunker A, Salter A, Ciorba M, Deepak P, Fowler K 2019 92

Pseudobulbar affect prevalence and association with symptoms inmultiple sclerosis

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Marrie RA 2018 Dec 8 472-481

Hepatopancreaticobiliary imaging second-opinion consultations: Is there value in the second reading?

Shetty AS, Mittal A, Salter A, Narra VR, Fowler KJ 2018 Dec 211 1264-1272

PDCB does not promote CNS autoimmunity in the context of genetic susceptibility but worsens its outcome

Dubey D, Hussain RZ, Miller-Little WA, Salter A, Doelger R, Stüve O 2018 Oct 323 53-55

Streamlined EDSS for use in multiple sclerosis clinical practice: Development and cross-sectional comparison to EDSS

Baldassari LE, Salter AR, Longbrake EE, Cross AH, Naismith RT 2018 Sep 24 1347-1355

Evaluation of noncontrast MR enterography for pediatric inflammatory bowel disease assessment

Lanier MH, Shetty AS, Salter A, Khanna G 2018 Aug 48 341-348

Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota

Cignarella F, Cantoni C, Ghezzi L, Salter A, Dorsett Y, Chen L, Phillips D, Weinstock GM, Fontana L, Cross AH, Zhou Y, Piccio L 2018 Jun 27 1222-1235.e6

A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry

Salter A, Thomas NP, Tyry T, Cutter GR, Marrie RA 2018 Jun 24 951-962

Synergy of sex differences in visceral fat measured with CT and tumor metabolism helps predict overall survival in patients with renal cell carcinoma

Nguyen GK, Mellnick VM, Yim AK, Salter A, Ippolito JE 2018 Jun 287 884-892

CAPTURE: Consistently Acquired Projections for Tuned and Robust Estimation: A Self-Navigated Respiratory Motion Correction Approach

Eldeniz C, Fraum T, Salter A, Chen Y, Gach HM, Parikh PJ, Fowler KJ, An H 2018 May 53 293-305

Risk factors and prognostic significance of altered left ventricular geometry in preterm infants

Choudhry S, Salter A, Cunningham TW, Levy PT, Hackett BP, Singh GK, Johnson MC 2018 May 38 543-549

A survey of dietary characteristics in a large population of people with multiple sclerosis

Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox RJ, Marrie RA 2018 May 22 12-18

Quantitative multiparametric mr analysis of small renal lesions: Correlation with surgical pathology

Yano M, Fowler KJ, Srisuwan S, Salter A, Siegel CL 2018 Apr 43 3390-3399

Endovascular Management of SVC Syndrome due to Fibrosing Mediastinitis—A Feasibility and Safety Analysis

Majumdar S, Shoela R, Kim DJ, Ramaswamy R, Mani N, Salter A, Akinwande O 2018 Apr 52 202-206

Denali, Tulip, and Option Inferior Vena Cava Filter Retrieval: A Single Center Experience

Ramaswamy RS, Jun E, van Beek D, Mani N, Salter A, Kim SK, Akinwande O 2018 Apr 41 572-577

Factors associated with excessive sitting time in multiple sclerosis

Sasaki JE, Motl RW, Cutter G, Marrie RA, Tyry T, Salter A 2018 Apr 21 71-77

Analysis of weight changes after left gastric artery embolization in a cancer-naive population

Kim DJ, Raman HS, Salter A, Ramaswamy R, Gunn AJ, Weiss CR, Akinwande O 2018 Mar 24 94-97

Thermal ablation versus surgical resection for localized hepatocellular carcinoma: A population study using the SEER database

Mills A, Thayer D, Noda C, Salter A, Tao Y, Xing M, Martin R, Ramaswamy R, Akinwande O 2018 Mar 14 631-645

Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis

Wang G, Marrie RA, Fox RJ, Tyry T, Cofield SS, Cutter GR, Salter A 2018 Feb 20 16-21

Clinical trials in multiple sclerosis: milestones

Zhang Y, Salter A, Cutter G, Stϋve O 2018 Jan 11

National estimates of self-reported sitting time in adults with multiple sclerosis

Sasaki JE, Motl RW, Cutter G, Marrie RA, Tyry T, Salter A 2018 Jan 4

Diffusion Tensor Imaging as a Biomarker to Differentiate Acute Disseminated Encephalomyelitis From Multiple Sclerosis at First Demyelination

Aung WY, Massoumzadeh P, Najmi S, Salter A, Heaps J, Benzinger TL, Mar S 2018 Jan 78 70-74

Diet quality is associated with disability and symptom severity in multiple sclerosis

Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox R, Marrie RA 2018 Jan 90 E1-E11

Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: Diagnostic performance of the liver imaging reporting and data system version 2014

Fraum TJ, Tsai R, Rohe E, Ludwig DR, Salter A, Nalbantoglu I, Heiken JP, Fowler KJ 2018 Jan 286 158-172

Shared decision making and autonomy among us participants with multiple sclerosis in the NARCOMS registry

Cofield SS, Nina Thomas T, Tyry T, Fox RJ, Salter A 2017 Nov 19 303-312

Pancreatic Neuroendocrine Tumors: Computed Tomography Enhancement, but Not Histological Grade, Correlates with Tumor Aggression

Yano M, Misra S, Carpenter DH, Salter A, Hildebolt CF 2017 Nov 46 1366-1372

Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 years

Lublin FD, Cofield SS, Cutter GR, Gustafson T, Krieger S, Narayana PA, Nelson F, Salter AR, Wolinsky JS 2017 Nov 18 95-102

Limbic system damage in MS: MRI assessment and correlations with clinical testing

Wen J, Yablonskiy DA, Salter A, Cross AH 2017 Nov 12

Traumatic brain injury in the prodromal period of Parkinson's disease: A large epidemiological study using medicare data

Camacho-Soto A, Warden MN, Searles Nielsen S, Salter A, Brody DL, Prather H, Racette BA 2017 Nov 82 744-754

The link between smoking status and co-morbid conditions in individuals with multiple sclerosis (MS)

Newland P, Flick L, Salter A, Dixon D, Jensen MP 2017 Oct 10 587-591

Author response: High hypothetical interest in physician-assisted death in multiple sclerosis

Marrie RA, Salter A, Tyry T, Cutter GR, Fox RJ 2017 Sep 89 1429-1430

Temporal evolution of disc in young patients with low back pain and stress reaction in lumbar vertebrae

Sharma A, Sargar K, Salter A 2017 Aug 38 1647-1652

Continuous In-Home Symptom and Mobility Measures for Individuals with Multiple Sclerosis: A Case Presentation

Newland P, Kimutis A, Salter A, Flick L, Thomas FP, Rantz M, Skubic M 2017 Aug 49 241-246

Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants

Cofield SS, Salter A, Tyry T, Crowe C, Cutter GR, Fox RJ, Marrie RA 2017 Aug 7 333-343

Normative Left Ventricular M-Mode Echocardiographic Values in Preterm Infants up to 2 kg

Choudhry S, Salter A, Cunningham TW, Levy PT, Nguyen HH, Wallendorf M, Singh GK, Johnson MC 2017 Aug 30 781-789.e4

Assessment of disease aggression in cystic pancreatic neuroendocrine tumors: A CT and pathology correlation study

Yano M, Misra S, Salter A, Carpenter DH 2017 Jul 17 605-610

Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary note

Wang G, Cutter GR, Cofield SS, Lublin F, Wolinsky JS, Gustafson T, Krieger S, Salter A 2017 Jun 23 982-987

Identity Concealment and Chronic Illness: A Strategic Choice

Cook JE, Salter A, Stadler G 2017 Jun 73 359-378

Employment and absenteeism in working-age persons with multiple sclerosis

Salter A, Thomas N, Tyry T, Cutter G, Marrie RA 2017 May 20 493-502

High hypothetical interest in physician-assisted death in multiple sclerosis

Marrie RA, Salter A, Tyry T, Cutter GR, Cofield S, Fox RJ 2017 Apr 88 1528-1534

Potentially Modifiable Factors Associated With Physical Activity in Individuals With Multiple Sclerosis

Reider N, Salter AR, Cutter GR, Tyry T, Marrie RA 2017 Apr 40 143-152

Upper limb impairment is associated with use of assistive devices and unemployment in multiple sclerosis

Marrie RA, Cutter GR, Tyry T, Cofield SS, Fox R, Salter A 2017 Apr 13 87-92

Assessment of Caregiver Inventory for Rett Syndrome

Lane JB, Salter AR, Jones NE, Cutter G, Horrigan J, Skinner SA, Kaufmann WE, Glaze DG, Neul JL, Percy AK 2017 Apr 47 1102-1112

Trigeminal neuralgia commonly precedes the diagnosis of multiple sclerosis

Fallata A, Salter A, Tyry T, Cutter GR, Marrie RA 2017 19 240-246

Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS

Salter A, Tyry T, Wang G, Fox RJ, Cutter G, Marrie RA 2016 Oct 6 397-408

Exploring the feasibility and acceptability of sensor monitoring of gait and falls in the homes of persons with multiple sclerosis

Newland P, Wagner JM, Salter A, Thomas FP, Skubic M, Rantz M 2016 Sep 49 277-282

Health insurance affects the use of disease-modifying therapy in multiple sclerosis

Wang G, Marrie RA, Salter AR, Fox R, Cofield SS, Tyry T, Cutter GR 2016 Jul 87 365-374

Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error?

Cutter GR, Salter A, Marrie RA 2016 Jul 22 983-985

Symptomatic management of multiple sclerosis-associated tremor among participants in the NARCOMS registry

Meador W, Salter AR, Rinker JR 2016 May 18 147-153

Relationship between symptom change, relapse activity and disability progression in multiple sclerosis

Liu Y, Morgan C, Hornung L, Tyry T, Salter AR, Agashivala N, Belletti DA, Kim E, Fox RJ, Cofield SS, Cutter GR 2016 Mar 362 121-126

Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice

Longbrake EE, Cross AH, Salter A 2016 Jan 2

Disability progression after switching from natalizumab to fingolimod or interferon beta/glatiramer acetate therapies: A NARCOMS analysis

Cofield SS, Fox RJ, Tyry T, Salter AR, Campagnolo D 2016 18 230-238

Two-group time-to-event continual reassessment method using likelihood estimation

Salter A, O'Quigley J, Cutter GR, Aban IB 2015 Nov 45 340-345

Implementation of a two-group likelihood time-to-event continual reassessment method using SAS

Salter A, Morgan C, Aban IB 2015 Oct 121 189-196

Causes of death among persons with multiple sclerosis

Cutter GR, Zimmerman J, Salter AR, Knappertz V, Suarez G, Waterbor J, Howard VJ, Ann Marrie R 2015 Sep 4 484-490

Risk tolerance to MS therapies: Survey results from the NARCOMS registry

Fox RJ, Salter A, Alster JM, Dawson NV, Kattan MW, Miller D, Ramesh S, Tyry T, Wells BW, Cutter G 2015 May 4 241-249

Impact of multiple sclerosis relapse: The NARCOMS participant perspective

Nickerson M, Cofield SS, Tyry T, Salter AR, Cutter GR, Marrie RA 2015 May 4 234-240

Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: A cross-sectional survey

Rinker JR, Salter AR, Walker H, Amara A, Meador W, Cutter GR 2015 5

Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS Registry

Fox RJ, Bacon TE, Chamot E, Salter AR, Cutter GR, Kalina JT, Kister I 2015 5 3-10

Patient perspectives on switching disease-modifying therapies in the NARCOMS registry

Salter AR, Marrie RA, Agashivala N, Belletti DA, Kim E, Cutter GR, Cofield SS, Tyry T 2014 Jul 8 971-979

Improvement of multiple sclerosis-associated tremor as a treatment effect of natalizumab

Rinker JR, Salter AR, Cutter GR 2014 Jul 3 505-512

"Seeing" in NARCOMS: A look at vision-related quality of life in the NARCOMS registry

Salter AR, Tyry T, Vollmer T, Cutter GR, Marrie RA 2013 Jun 19 953-960

Preferred sources of health information in persons with multiple sclerosis: Degree of trust and information sought

Marrie RA, Salter AR, Tyry T, Fox RJ, Cutter GR 2013 Apr 15

Disability in multiple sclerosis: A reference for patients and clinicians

Kister I, Chamot E, Salter AR, Cutter GR, Bacon TE, Herbert J 2013 Mar 80 1018-1024

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

Lublin FD, Cofield SS, Cutter GR, Conwit R, Narayana PA, Nelson F, Salter AR, Gustafson T, Wolinsky JS 2013 Mar 73 327-340

Treatment discontinuation and disease progression with injectable disease-modifying therapies: Findings from the north american research committee on multiple sclerosis database

Fox RJ, Salter AR, Tyry T, Sun J, You X, Laforet G, Campagnolo D 2013 15 194-201

Natural history of multiple sclerosis symptoms

Kister I, Bacon TE, Chamot E, Salter AR, Cutter GR, Kalina JT, Herbert J 2013 15 146-158

Measures of neurological impairment and disability in multiple sclerosis

Cutter GR, Morgan CJ, Salter AR, Coield SS, Balcer LJ 2011 Dec 56-64

Got milk?

Cutter G, Salter A 2011 Jul 70 3-4

Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS

Salter AR, Cutter GR, Tyry T, Marrie RA, Vollmer T 2010 Feb 26 493-500

A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS)

Remington GM, Treadaway K, Frohman T, Salter A, Stuve O, Racke MK, Hawker K, Agosta F, Sormani MP, Filippi M, Frohman E 2010 Jan 3 3-13

A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis

Frohman E, Cutter G, Remington G, Gao H, Rossman H, Weinstock-Guttman B, Durfee JE, Conger A, Carl E, Stuve O, Greenberg B, Salter A, Frohman TC, Shah A, Bates A, Cox JL, Dwyer MG, Shah A, Greenberg BM, Racke MK, Zivadinov R 2010 Jan 3 15-28

Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: A pilot study

Frohman E, Dwyer MG, Frohman T, Cox JL, Salter A, Greenberg B, Hussein S, Conger A, Calabresi P, Balcer LJ, Zivadinov R 2009 Jul 282 96-105

Factors that influence adherence with disease-modifying therapy in MS

Treadaway K, Cutter G, Salter A, Lynch S, Simsarian J, Corboy J, Jeffery D, Cohen B, Mankowski K, Guarnaccia J, Schaeffer L, Kanter R, Brandes D, Kaufman C, Duncan D, Marder EJ, Allen A, Harney J, Cooper J, Woo D, Stuve O, Racke M, Frohman E 2009 Apr 256 568-576

Retinal architecture predicts pupillary reflex metrics in MS

Salter AR, Conger A, Frohman TC, Zivadinov R, Eggenberger E, Calabresi P, Cutter G, Balcer L, Frohman E 2009 15 479-486

Reproducibility of optical coherence tomography in multiple sclerosis

Cettomai D, Pulicken M, Gordon-Lipkin E, Salter A, Frohman TC, Conger A, Zhang X, Cutter G, Balcer LJ, Frohman E, Calabresi PA 2008 Sep 65 1218-1222

Break in binocular fusion during head turning in MS patients with INO

Mills DA, Frohman TC, Davis SL, Salter AR, McClure S, Beatty I, Shah A, Galetta S, Eggenberger E, Zee DS, Frohman E 2008 Aug 71 458-460

Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis

Zaveri MS, Conger A, Salter A, Frohman TC, Galetta SL, Markowitz CE, Jacobs DA, Cutter GR, Ying GS, Maguire MG, Calabresi PA, Balcer LJ, Frohman E 2008 Jul 65 924-928

Modeling axonal degeneration within the anterior visual system: Implications for demonstrating neuroprotection in multiple sclerosis

Frohman E, Costello F, Stuve O, Calabresi P, Miller DH, Hickman SJ, Sergott R, Conger A, Salter A, Hoggatt KA, Frohman TC, Balcer L, Zivadinov R 2008 Jan 65 26-35

Accuracy of clinical detection of INO in MS: Corroboration with quantitative infrared oculography

Frohman TC, Frohman E, O'Suilleabhain PE, Salter A, Dewey RB, Hogan RN, Galetta S, Lee AG, Straumann D, Noseworthy J, Zee D, Corbett J, Corboy J, Rivera VM, Kramer PD 2003 Sep 61 848-850